Privi Speciality Chemicals Limited has informed the Exchange regarding Change in Director(s) of the company.
PRIVISCL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
The Board of Directors of Privi Speciality Chemicals approved the audited financial results for Q4 and FY2026. Standalone revenue grew to Rs. 2,45,553 lakhs from Rs. 2,03,834 lakhs in FY2025, while consolidated revenue stood at Rs. 2,56,369 lakhs. However, the consolidated entity reported a net loss due to subsidiary losses of Rs. 3,586 lakhs. The Board recommended a final dividend of Rs. 10 per share (100% on face value of Rs. 10), totaling Rs. 3,906.27 lakhs, subject to shareholder approval at the 41st AGM on August 7, 2026. Record date is July 31, 2026. The meeting also approved re-appointment of Mr. Bhaktavatsala Rao Doppalapudi as Executive Director for 3 years, re-appointed internal auditor M/s Aneja Associates, and cost auditor M/s Kishore Bhatia & Associates for FY2026-27. Statutory auditors BSR & Co. LLP gave an unmodified opinion on the financial results.
Positive sentiment from revenue growth and dividend declaration, though the consolidated net loss due to subsidiary performance may concern some investors. The headline about director change appears misleading since only a director re-appointment (not resignation or new appointment) was approved.